Lim, Chi-Yeon
Ko, Mun Jung
Lee, Jin Won
Bok, Soo Kyung
Paik, Nam-Jong
Nam, Yeon Gyo
Kwon, Bum Sun https://orcid.org/0000-0001-7755-435X
Funding for this research was provided by:
Korea Health Industry Development Institute (HI18C2324)
Article History
Received: 31 March 2021
Accepted: 16 August 2022
First Online: 2 September 2022
Declarations
:
: This research protocol was approved by Dongguk University Ilsan Hospital’s Institutional Review Board (IRB No. DUIH 2018-08-026-001, version N/A), Chungnam National University Hospital’s IRB (IRB No. CNUH 2018-09-033, version N/A), and Seoul National University Bundang Hospital’s IRB (IRB No. B-1810/497-001, version 1.0). The researcher conducts the study in compliance with the Declaration of Helsinki and the International Conference on Harmonization-Good Clinical Practice (ICH-GCP) and initiates the study after IRB approval.When the protocol is revised, the researcher of the institution proceeds with the IRB approval using the research protocol of the approval form written following the SOP.Each participant provides informed consent before enrollment. The research director explains the contents of the consent form to the patient for 30 min using terms that are easy for the general public to understand. The participants are provided with one copy of the signed consent form. This trial does not involve collecting biological specimens for storage.
: The authors declare that they have no competing interests.